This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: Paul Buchschacher: Innovator in Steroid Chemistry
Introduction
Paul Buchschacher is a notable inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of steroid chemistry, particularly through his innovative patent work. His research focuses on the methylation of de-A steroids, which has implications for medicinal chemistry.
Latest Patents
Buchschacher holds a patent for the methylation of de-A steroids. This patent describes a method for treating de-A steroids with a methylation agent at extremely low temperatures, specifically below -50 degrees Celsius. This process produces corresponding 10.beta.-methyl-.DELTA.9(11)-deA steroids with a high 10.beta. to 10.alpha. isomer ratio. Notably, several of the resulting 10.beta.-methyl-.DELTA.9(11)-deA steroids are novel compounds. These compounds are valuable as intermediates in the synthesis of known medicinally valuable steroids.
Career Highlights
Buchschacher's career is marked by his dedication to advancing steroid chemistry. His innovative approaches have led to breakthroughs that enhance the understanding and application of steroid compounds in medicine. His work has garnered attention in the scientific community for its potential therapeutic applications.
Collaborations
Throughout his career, Buchschacher has collaborated with esteemed colleagues, including Andor Furst and Ludwig Labler. These collaborations have contributed to the advancement of research in steroid chemistry and have fostered a productive scientific environment.
Conclusion
Paul Buchschacher's contributions to the field of steroid chemistry through his innovative patent work highlight his role as a significant inventor. His research not only advances scientific knowledge but also has practical implications for medicinal applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
